Stock UniverseDerived research view · source repositories remain read-only

Alkermes plc (ALKS)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Watch
Selection Score
33.63
Global Rank
1471
Market Cap
5.02B
Latest Close
42.80
RS Composite
38.01% · G#210

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
21.18%
3M
49.49%
6M
44.94%
1Y
35.70%
3Y
47.94%
5Y
88.80%
10Y
-7.78%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.30M · 30-day average: 2.15M · Max drawdown over stored range: -80.58%

Research Snapshot

Relative Strength vs SPX

RS Composite38.01%
20D RS20.27%
60D RS45.15%
120D RS39.73%
Global RS Rank210 · 93.74% percentile
Watch+Speculative RS Rank117 · 94.42% percentile
Group ScopeWatch+Speculative
Primary RS Rank35 · 92.36% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank192 / 701
Primary Percentile72.75
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-051.56Bn/a191.88M152.72M0.91604.02M67.64M536.39M168Mn/a12.28%9.78%38.66%34.33%351.55M1.48B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$0.9147.1x$9.294.6x$3.1913.4x$3.5911.9x

Shares Diluted: 168M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1038.7561173.7511111.7951663.4051557.6321475.899
Revenue Growth (YoY)-11.289%12.996%-5.278%49.614%-6.359%-5.247%
Gross Profit860.44976.428893.7271410.3681312.3011279.442
Operating Income-112.42797.746-6.089414.122420.636253.956
Free Cash Flow40.62373.695-17.211353.305405.64480.334
Free Cash Flow Per Share0.2560.447-0.1052.0822.3972.847
EPS (Diluted) GAAP-0.698103-0.296101-0.9665632.0972942.1700461.43
EPS Growth12500%12500%12500%12500%3.469%-34.103%
EPS Non-GAAP
Gross Margin82.834%83.189%80.386%84.788%84.25%86.689%
Operating Margin-10.823%8.328%-0.548%24.896%27.005%17.207%
Profit Margin-10.672%-4.104%-14.235%21.387%23.566%16.374%
Free Cash Flow Margin3.911%6.279%-1.548%21.24%26.042%32.545%
Shares Outstanding (Diluted)158.803164.753163.742169.73169.198168.743
Shares Change (YoY)1.116%3.747%-0.614%3.657%-0.313%-0.269%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-05392.91Mn/a-48.28M-12.29%-66.48M-16.92%-0.40166.20M351.55M1.48Bprocessed
2025 Q42026-02-25384.55Mn/a58.10M15.11%49.34M12.83%0.29169.64M388.57Mn/aprocessed
2025 Q32025-10-28394.19Mn/a89.08M22.60%82.76M21.00%0.49168.51M616.45Mn/aprocessed
2025 Q22025-07-29390.66Mn/a92.98M23.80%87.10M22.30%0.52168.36M521.20Mn/aprocessed
2025 Q12025-05-01306.51Mn/a13.79M4.50%22.46M7.33%0.13168.74M399.81Mn/aprocessed
2024 Q42025-02-12429.99Mn/a162.69M37.84%146.50M34.07%0.88166.20M291.15M287.73Mprocessed
2024 Q32024-10-24378.14Mn/a104.76M27.70%92.38M24.43%0.55167.03M396.29M285.82Mprocessed
2024 Q22024-07-24399.13Mn/a109.88M27.53%91.36M22.89%0.53170.98M535.15M286.46Mprocessed
2024 Q12024-05-01350.37Mn/a43.31M12.36%36.83M10.51%0.21172.98M420.75M287.10Mprocessed
2023 Q42024-02-21377.48Mn/a178.57M47.31%112.78M29.88%0.68165.98M457.47M287.73Mprocessed
2023 Q32023-10-25380.94Mn/a43.85M11.51%47.76M12.54%0.28171.90M647.71M288.37Mprocessed
2023 Q22023-07-26617.40Mn/a239.19M38.74%237.06M38.40%1.38171.55M665.79M289.00Mprocessed
2023 Q12023-04-26287.60Mn/a-47.49M-16.51%-41.84M-14.55%-0.25165.09M321.40M289.63Mprocessed
2022 Q42023-02-16304.67Mn/a-20.58M-6.76%-28.25M-9.27%-0.17163.54M292.47M290.27Mprocessed
2022 Q32022-11-02252.36Mn/a-60.64M-24.03%-63.97M-25.35%-0.39164.28M263.96M290.90Mprocessed
2022 Q22022-07-27276.22Mn/a-34.46M-12.47%-30.14M-10.91%-0.18163.84M254.65M291.54Mprocessed
2022 Q12022-04-27278.55Mn/a-26.59M-9.54%-35.90M-12.89%n/an/a282.56M292.17Mprocessed
2021 Q42022-02-16324.46Mn/a2.38M0.73%873.00K0.27%n/an/a536.31M292.80Mprocessed
2021 Q32021-10-27294.14Mn/a-19.66M-6.68%-28.99M-9.86%n/an/a560.30M293.44Mprocessed
2021 Q22021-07-28303.72Mn/a4.42M1.46%2.36M0.78%n/a163.94M538.35M294.07Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.